EVENT POSTPONED DUE TO COVID-19
To safeguard against COVID-19, the decision has been made to postpone this event.
We are working with the venue to schedule a new date later this year. Please accept our apologies for any inconvenience or disappointment this will cause.
Register your interest here to get updates.
Making Allogeneic Cell Therapies the Gold Standard to Deliver the Next Generation of Safe, Effective & Commercially Viable Cell Therapies
The Allogeneic Cell Therapies Summit is the leading industry-dedicated meeting focused on the translation, manufacturing and commercialization of allogeneic cell therapies to improve persistence, optimize manufacturing protocols and streamline logistical supply chains.
Join over 250 of the industry’s leading minds as we drive towards the future of cell therapy with allogeneic cell therapy approaches that are enhanced through engineering, boasting simpler and more cost-effective manufacturing strategies with improved commercial benefits.
As we gather the leaders in allogeneic cell therapy over 3 tracks of hotly anticipated case studies exclusively focused on the translation, manufacturing and logistical challenges, we bring you the leading and unmissable Allogeneic Cell Therapies Summit.
"High level and relevant exchange of experience in a very comfortable and friendly atmosphere with great people."
PHD Candidate, Charité Universitätsmedizin Berlin
"Very informative summit with lots of great material, knowledgeable and engaging speakers and overall a fantastic experience."
Non-clinical Safety Lead, Johnson & Johnson
"This was a very nice event. The focus on Allogeneic was really good and this summit provided an opportunity to have a more holistic view of the field and its potential. Very well done!"
Chief Operations Officer, Celyad